New Vista Post-acute Care Center
NEW VISTA POST-ACUTE CARE CENTER in LOS ANGELES, CA — inspection on July 25, 2024.
Found 2 citations. Severity: Standard violations.
Health inspections identify deficiencies that facilities must correct within required timeframes. Violations range from minor documentation issues to serious safety concerns and are subject to follow-up verification.
Inspection Findings
During a review of Resident 4's Physician Orders, dated 5/23/2024, indicated a physician's orders scheduled at 9:00 a.m. for the following medications:
Multivitamin-Minerals (supplement) 1 tablet via gastrostomy (GT- a flexible tube surgically inserted through the abdomen into the stomach for feeding, fluid, and medication administration)daily
Docusate Sodium (DSS-stool softener) 100 milligram (mg) via GT daily
Cranberry (supplement) 500 mg via GT daily
Famotidine (acid controller) 40 mg via GT twice a day
Amlodipine Besylate (medication to treat high blood pressure) 10 mg via GT daily, hold if systolic blood pressure is less than 100
Vitamin C (supplement) 500 mg via GT daily
Arginaid (protein powder) 1 packet via GT daily
During a review of Resident 4's Minimum Data Set (MDS - a comprehensive standardized assessment and care screening tool), dated 5/29/2024, indicated Resident 4's cognitive (mental action or process of acquiring knowledge and understanding) skills for daily decision-making was severely impaired and dependent from staff for activities of daily living (ADLs- bed mobility, transfer, dressing, and toilet use).
During a review of Resident 4's Medication Administration Record (MAR), dated 7/25/2024, indicated scheduled medications at 9 a.m., were administered at 11:45 for the following medications:
055473
Form Approved OMB
STATEMENT OF DEFICIENCIES (X1) PROVIDER/SUPPLIER/CLIA (X2) MULTIPLE CONSTRUCTION (X3) DATE SURVEY AND PLAN OF CORRECTION IDENTIFICATION NUMBER: COMPLETED A.
Building 055473 B.
Wing 07/25/2024
NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE
New Vista Post-Acute Care Center 1516 Sawtelle Blvd.
Los Angeles, CA 90025
During a review of Resident 4's Physician Orders, dated 5/23/2024, indicated a physician's orders scheduled at 9:00 a.m. for the following medications:
Multivitamin-Minerals (supplement) 1 tablet via gastrostomy (GT- a flexible tube surgically inserted through the abdomen into the stomach for feeding, fluid, and medication administration)daily
Docusate Sodium (DSS-stool softener) 100 milligram (mg) via GT daily
Cranberry (supplement) 500 mg via GT daily
Famotidine (acid controller) 40 mg via GT twice a day
Amlodipine Besylate (medication to treat high blood pressure) 10 mg via GT daily, hold if systolic blood pressure is less than 100
Vitamin C (supplement) 500 mg via GT daily
Arginaid (protein powder) 1 packet via GT daily
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided.
For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER TITLE (X6) DATE REPRESENTATIVE'S SIGNATURE
055473
Form Approved OMB
STATEMENT OF DEFICIENCIES (X1) PROVIDER/SUPPLIER/CLIA (X2) MULTIPLE CONSTRUCTION (X3) DATE SURVEY AND PLAN OF CORRECTION IDENTIFICATION NUMBER: COMPLETED A.
Building 055473 B.
Wing 07/25/2024
NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE
New Vista Post-Acute Care Center 1516 Sawtelle Blvd.
Los Angeles, CA 90025